Phase I multiple-escalating dose trial to evaluate the safety, tolerability and pharmacokinetics of dextromethodone in healthy volunteers

Trial Profile

Phase I multiple-escalating dose trial to evaluate the safety, tolerability and pharmacokinetics of dextromethodone in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jan 2016

At a glance

  • Drugs Dextromethadone (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms MAD
  • Sponsors Relmada Therapeutics
  • Most Recent Events

    • 04 Jan 2016 Status changed from planning to completed, as per Remalda Therapeutics media release.
    • 17 Aug 2015 Relmada Therapeutics received a no objection letter from Health Canada to conduct this study, according to a company media release.
    • 10 Jun 2015 According to a Relmada Therapeutics media release, this trial is expected to start in the second half of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top